RedaAAKaperJFikrelterH. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev.2009;(2):CD004305.
5.
SalizeJHMerkelSReinhardI. Cost-effective primary care-based strategies to improve smoking cessation: more value for money. Arch Intern Med.2009;169:230–235.
6.
SchaufflerHHMcMenanminSOlsonK. Variations in treatment benefits influence smoking cessation: results of a randomized controlled trial. Tob Control.2001;19:175–180.
7.
CurrySJGrothausLCMcAfeeTPabiniakC. Use and cost effectiveness of smoking cessation services under four insurance plans in a health maintenance organization. N Engl J Med.1998;339:673–679.
8.
CurrySJKellerPAOrleansCTFioreMC. The role of health care systems in increased tobacco cessation. Annu Rev Public Health.2008;29:411–428.
9.
GollustSESchroederSAWarnerKE. Helping smokers quit: understanding the barriers to utilization of smoking cessation services. Milbank Q.2008;86:601–627.
10.
PiaseckiTM. Relapse to smoking. Clin Psychol Rev.2006;26:196–215.
11.
HoltropJSMalouinRWismantelDWadlandWC. Clinician perceptions of factors influencing referrals to a smoking cessation program. BMC Fam Pract.2008;9:18.
12.
ZhuSHMelcerTSunJ. Smoking cessation with and without assistance. Am J Prev Med.2000;18:305–311.
13.
RoskiJJeddelohRAnL. The impact of financial incentives and a patient registry on preventive care quality: increasing provider adherence to evidence-based smoking cessation practice guidelines. Prev Med.2003;36:291–299.
14.
ShermanSETakahashiNKalraP. Care coordination to increase referrals to smoking cessation telephone counseling: a demonstration project. Am J Manag Care.2008;14:141–148.
MaciosekMVCoffieldAREdwardsNM. Priorities among effective clinical preventive services. Results of a systematic review and analysis. Am J Prev Med.2006;31:52–61.
17.
JohnstonSSMarkTLDiraniR. Smoking cessation: the value of a comprehensive carved-in benefit. Am J Health Promot.2008;23:85–87.
18.
RondiMAHarrisJRAtkinsD. Employer coverage of clinical preventive services in the United States. Am J Health Promot.2006;20:214–222.
19.
RushTMMcAfeeTDepreyM. The impact of a free nicotine patch starter kit on quit rates in a state quit line (Free & Clear). Nicotine Tob Res.2008;10:1511–1516.
20.
RoyleRGSolbergLIMagnanS. Does insurance coverage for drug therapy affect smoking cessation?Health Aff (Millwood).2002;21:162–168.
21.
BurnsMERosenbergMAFioreMC. Use of a new comprehensive insurance benefit for smoking cessation. Prev Chronic Dis.2005;2:A15.
22.
VogtFHallSMarteauTM. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies. Nicotine Tob Res.2008;10:1405–1413.
23.
McEwenAWestRMcRobbieH. Motives for smoking and their correlates in clients attending stop smoking treatment services. Nicotine Tob Res.2008;10:843–850.
24.
GregorKLZvolenskyMJMcLeishAC. Anxiety sensitivity and perceived control over anxiety-related events: associations with smoking outcome expectancies and perceived cessation barriers among daily smokers. Nicotine Tob Res.2008;10:627–635.
25.
GrahamALPapandonatosGDDePueJD. Lifetime characteristics of participants and non-participants in a smoking cessation trial: implications for external validity and public health impact. Ann Behav Med.2008;35:295–307.
26.
PerkinsKALermanCStitzerM. Development of procedures for early screening of smoking cessation medications in humans. Clin Pharmacol Ther.2008;84:216–221.
27.
CahillKPereraR. Competitions and incentives for smoking cessation. Cochrane Database Syst Rev.2008;(3):CD004307.
28.
DonatelleRJHudsonDDobieS. Incentives in smoking cessation: status of the field and implication for research and practice with pregnant smokers. Nicotine Tob Res.2004;6(suppl 2):S163–S179.
29.
GrahamALCobbNKRaymondL. Effectiveness of an Internet-based worksite smoking cessation intervention at 12 months. J Occup Environ Med.2007;49:821–828.
30.
VolppKGTroxelARPaulyMV. A randomized controlled trial of financial incentives for smoking cessation. N Engl J Med.2009;360:699–709.
31.
JavitzHSSwanGEZbikowskiSM. Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective. Value Health.2004;7:535–543.
32.
KaperJWagenaEJWillemsenMCvan SchayckCP. A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence. Addiction.2006;101:1656–1661.
33.
AveyardPMasseyLParsonsA. The effect of transtheoretical model based interventions on smoking cessation. Soc Sci Med.2009;68:397–403.
34.
AnLCRluhmJHFoldesSS. A randomized trial of a pay-for-performance program targeting clinician referral to a state tobacco quitline. Arch Intern Med.2008;168:1993–1999.
35.
RaupachTShahabLNeubertK. Implementing a hospital-based smoking cessation program: evidence for a learning effect. Patient Educ Couns.2008;70:199–204.
MiguezMCReconaE. Evaluation the effectiveness of a single telephone contact as an adjunct to self-help intervention for smoking cessation in a randomized controlled trial. Nicotine Tob Res.2008;10:129–135.
38.
SteadLFPereraRLancasterT. Telephone counseling for smoking cessation. Cochrane Database Syst Rev.2006;3:CD002850.
39.
RauldLChestermanJFergusonJJudgeK. A comparison of the effectiveness of a group-based and pharmacy-led smoking cessation treatment in Glasgow. Addiction.2009;104:308–316.
40.
MillerNFriedenTRLiuSY. Effectiveness of a large scale distribution program of free nicotine patches: a prospective evaluation. Lancet.2005;365:1849–1854.
41.
WestRRakerCLCappelleriJCRushmakinAG. Effect of varenicline and bupropion ST on craving, nicotine withdrawal symptoms and rewarding effects of smoking during a quit attempt. Psychopharmacology (Berl).2008;197:371–377.
42.
ChristakisNAFowlerJH. The collective dynamics of smoking in a large social network. N Engl J Med.2008;358:2249–2258.
43.
van OschLLechnerLReubsaetA. Optimizing the efficacy of smoking cessation contests: an exploration of determinants of successful quitting. Health Educ Res.2009;24:54–63.
44.
DonatelleRJProwsSLChampeauDHudsonD. Randomized controlled trial using social support and financial incentives for high risk pregnant smokers: significant other supporter (SOS) program. Tob Control.2000;9:iii67–iii69.
45.
RarbeauEMLiYCalderonP. Results of a union-based smoking cessation intervention for apprentice iron workers (US). Cancer Causes Control.2006;17:53–61.
46.
LancasterTHajekPSteadLF. Prevention of relapse after quitting smoking: a systematic review of trials. Arch Intern Med.2006;166:828–833.
47.
TonstadSTonnesenPHajekP. Effect of maintenance therapy with varenicline on smoking cessation. JAMA.2006;296:64–71.
TaylorAHUssherMHFaulknerG. The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect and smoking behavior: a systematic review. Addiction.2007;102:534–543.
50.
UssherMHTaylorAFaulknerG. Exercise interventions for smoking cessation. Cochrane Database Syst Rev.2008;(4):CD002295.
51.
CahillKSteadLLancasterT. A preliminary benefit-risk assessment of varenicline in smoking cessation. Drug Saf.2009;32:119–138.
52.
RurnsEKLevinsonAH. Discontinuation of nicotine replacement therapy among smoking-cessation attempts. Am J Prev Med.2008;34:212–215.
53.
CarterRLLamCYRobinsonJD. Real-time craving and mood assessments before and after smoking. Nicotine Tob Res.2008;10:1165–1169.
54.
HallSMHumfleetFLMunozRF. Extended treatment of older cigarette smokers. Addiction.2009;104:1043–1052.
55.
WadlandWCHoltropJWeimantelD. Practice-based referrals to a tobacco cessation quit line: assessing the impact of comparative feedback vs general reminders. Ann Fam Med.2007;5:135–142.
56.
AnLCZhuSHNielsonDR. Renefits of telephone care over primary care for smoking cessation. A randomized trial. Arch Intern Med.2006;166:536–542.
57.
CahillKMoherMLancasterT. Workplace interventions for smoking cessation. Cochrane Database Syst Rev.2008;(4):CD003440.
58.
SchumannAJohnURaumeisterSE. Computer-tailored smoking cessation intervention in a general population setting in Germany: outcome of a randomized controlled trial. Nicotine Tob Res.2008;10:371–379.
59.
ShiffmanSFergusonSGRohayJGitchellJG. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship between use and compliance. Addiction.2008;103:1371–1378.
60.
NidesMGloverEDReusVI. Varenicline versus bupropion SR or placebo for smoking cessation. Am J Health Behav.2008;32:664–675.
61.
WoolfNHRurnsMERosworthTWFioreMC. Purchasing health insurance coverage for smoking cessation treatment: employers describe the most influential information in this decision. Nicotine Tob Res.2006;8:717–725.